Kidney Transplant Rejection Market to Observe Growth at a CAGR of 4.9% During the Forecast Period (2024-2034) | DelveInsight

The kidney transplant rejection prophylaxis market is projected to experience steady growth, driven by the introduction of innovative therapies such as MDR-101, tegoprubart (AT-1501), riliprubart (BIVV020, SAR445088), and TRK-001 (Treg). Additionally, the growing number of kidney…